Microbot Medical (MBOT) Shares Outstanding (2010 - 2026)

Microbot Medical (MBOT) has 17 years of Shares Outstanding data on file, last reported at $67.2 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding rose 93.29% year-over-year to $67.2 million; the trailing twelve-month figure through Mar 2026 stood at $67.2 million (up 93.29% YoY), and the FY2025 full-year result was $67.2 million, up 246.18% from the prior year.
• Shares Outstanding for Q1 2026 stood at $67.2 million, roughly flat from $67.2 million in the prior quarter.
• Across five years, Shares Outstanding topped out at $67.2 million in Q4 2025 and bottomed at $7.1 million in Q1 2022.
• The 5-year median for Shares Outstanding is $14.4 million (2024), against an average of $24.2 million.
• The widest annual swing landed in 2022, when Shares Outstanding changed 0.0%; it then surged 295.36% in 2025.
• A 5-year view of Shares Outstanding shows it stood at $7.9 million in 2022, then jumped by 48.37% to $11.7 million in 2023, then jumped by 65.7% to $19.4 million in 2024, then soared by 246.18% to $67.2 million in 2025, then changed by 0.0% to $67.2 million in 2026.
• The last three Shares Outstanding figures came in at $67.2 million (Q1 2026), $67.2 million (Q4 2025), and $65.8 million (Q3 2025), per Business Quant data.

Peer Comparison